Clinical outcomes and management following progressive disease with anti-PD-(L)1 therapy in patients with advanced Merkel Cell Carcinoma
European Journal of Cancer · 2025
DOI: 10.1016/j.ejca.2025.115254 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Jeremy Mo und 32 weiteren Autor:innen. Beteiligte Einrichtung: Westmead Hospital, Westmead, Australia. Hauptthemen laut MEDLINE: Carcinoma, Merkel Cell, Skin Neoplasms, Immune Checkpoint Inhibitors, B7-H1 Antigen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Health and Medical Research Council, University of Sydney.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Westmead Hospital, Westmead, Australia.
- Department of Dermatology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
- Sir Charles Gairdner Hospital, Nedlands, Western Australia; Peter MacCallum Cancer Centre, Melbourne, Australia.
- Université Paris Cité, AP-HP Dermato-Oncology Paris France.
- Princess Alexandra Hospital, Brisbane, Australia.
- Lausanne University Hospital, Lausanne, Switzerland.
Förderung
- National Health and Medical Research Council
- University of Sydney
Zitieren
APA
Mo, J., Zaremba, A., Inderjeeth, A. J., El Zeinaty, P., Li, A., Wicky, A., Della Marta, N., Gaudy-Marqueste, C., Bohne, A. S., Matias, M., McNamee, N., Festino, L., Chen, C., Ch'ng, S., van Akkooi, A. C. J., Meda, L. D., Park, J. J., Ascierto, P. A., Hauschild, A., …, & da Silva, I. P. (2025). Clinical outcomes and management following progressive disease with anti-PD-(L)1 therapy in patients with advanced Merkel Cell Carcinoma. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.115254
Vancouver
Mo J, Zaremba A, Inderjeeth AJ, El Zeinaty P, Li A, Wicky A, et al. Clinical outcomes and management following progressive disease with anti-PD-(L)1 therapy in patients with advanced Merkel Cell Carcinoma. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.115254
BibTeX
@article{Mo2025,
author = {Mo, Jeremy and Zaremba, Anne and Inderjeeth, Andrisha-Jade and El Zeinaty, Perla and Li, Ao and Wicky, Alexandre and Della Marta, Nicholas and Gaudy-Marqueste, Caroline and Bohne, Ann-Sophie and Matias, Margarida and McNamee, Nicholas and Festino, Lucia and Chen, Charley and Ch'ng, Sydney and van Akkooi, Alexander C J and Meda, Laetitia Da and Park, John J and Ascierto, Paolo A and Hauschild, Axel and Lee, Jenny H and Grob, Jean Jacques and Mangana, Joanna and Guminski, Alex and Michielin, Olivier and Xu, Wen and Lebbe, Celeste and Sandhu, Shahneen and Zimmer, Lisa and Menzies, Alexander M and Lo, Serigne N and Long, Georgina V and Carlino, Matteo S and da Silva, Ines Pires},
title = {Clinical outcomes and management following progressive disease with anti-PD-(L)1 therapy in patients with advanced Merkel Cell Carcinoma},
journal = {European Journal of Cancer},
year = {2025},
doi = {10.1016/j.ejca.2025.115254}
}
EUVIMED